Teladoc Health, Inc. (NYSE:TDOC) Shares Purchased by KBC Group NV

KBC Group NV increased its position in shares of Teladoc Health, Inc. (NYSE:TDOCFree Report) by 72.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 8,849 shares of the health services provider’s stock after acquiring an additional 3,714 shares during the period. KBC Group NV’s holdings in Teladoc Health were worth $80,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of TDOC. Versant Capital Management Inc lifted its stake in Teladoc Health by 313.8% during the 4th quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider’s stock worth $29,000 after acquiring an additional 2,441 shares in the last quarter. Blue Trust Inc. raised its position in Teladoc Health by 84.5% in the 3rd quarter. Blue Trust Inc. now owns 4,048 shares of the health services provider’s stock valued at $40,000 after purchasing an additional 1,854 shares in the last quarter. Signaturefd LLC raised its position in Teladoc Health by 162.7% in the 3rd quarter. Signaturefd LLC now owns 7,535 shares of the health services provider’s stock valued at $69,000 after purchasing an additional 4,667 shares in the last quarter. Westside Investment Management Inc. raised its position in Teladoc Health by 43.8% in the 4th quarter. Westside Investment Management Inc. now owns 9,200 shares of the health services provider’s stock valued at $84,000 after purchasing an additional 2,800 shares in the last quarter. Finally, GSA Capital Partners LLP acquired a new stake in Teladoc Health in the 3rd quarter valued at about $92,000. Institutional investors and hedge funds own 76.82% of the company’s stock.

Teladoc Health Trading Up 8.4 %

Shares of TDOC stock opened at $12.98 on Monday. The business’s 50 day moving average is $10.05 and its two-hundred day moving average is $9.14. Teladoc Health, Inc. has a twelve month low of $6.76 and a twelve month high of $21.74. The company has a market capitalization of $2.23 billion, a P/E ratio of -2.25 and a beta of 1.05. The company has a current ratio of 1.73, a quick ratio of 1.69 and a debt-to-equity ratio of 0.66.

Analyst Upgrades and Downgrades

TDOC has been the topic of a number of analyst reports. Bank of America increased their price target on Teladoc Health from $10.50 to $11.50 and gave the company a “neutral” rating in a research report on Thursday. TD Cowen dropped their price objective on Teladoc Health from $9.00 to $8.00 and set a “hold” rating on the stock in a report on Thursday, October 31st. Royal Bank of Canada increased their price objective on Teladoc Health from $11.00 to $12.00 and gave the company an “outperform” rating in a report on Friday, January 24th. Barclays increased their price objective on Teladoc Health from $10.00 to $12.00 and gave the company an “overweight” rating in a report on Thursday, October 31st. Finally, Deutsche Bank Aktiengesellschaft increased their price objective on Teladoc Health from $10.00 to $12.00 and gave the company a “hold” rating in a report on Friday, November 1st. Fourteen analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $11.97.

Get Our Latest Research Report on TDOC

Insider Buying and Selling at Teladoc Health

In other news, insider Carlos Nueno sold 2,389 shares of the firm’s stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $11.93, for a total value of $28,500.77. Following the completion of the sale, the insider now directly owns 2,890 shares of the company’s stock, valued at $34,477.70. This trade represents a 45.25 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 0.95% of the company’s stock.

About Teladoc Health

(Free Report)

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

Further Reading

Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Health, Inc. (NYSE:TDOCFree Report).

Institutional Ownership by Quarter for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.